Immuno-inflammation in the Acute Phase of an Ischaemic Cerebral Accident Managed by Decompressive Hemicraniectomy: a Case-control Study

ConditionIschemic Cerebrovascular Accident

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorFondation Ophtalmologique Adolphe de Rothschild

About this trial

The objective of the NEUTROSURGERY study is to describe the local and locoregional immuno-inflammatory activity in patients suffering from malignant sylvian ischaemic cerebral accident and treated with decompressive hemicraniectomy compared to a control population of patients to be operated on in neurosurgery for another neurosurgical pathology.

Eligibility criteria

Qualifiers

Collegial indication given by a neurologist, a neuroreanimator and a neurosurgeon for HD in the context of a malignant sylvian AIC.

HD carried out in a context of acute cerebral haemorrhage

Pre-existing neurological disability: modified Rankin score > 2

Patient benefiting from a legal protection measure

Disqualifiers

None

Trial design

Treatments tested in this trial

Decompressive hemicraniectomy
neurosurgical operation

Treatment groups

90 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Fondation Ophtalmologique Adolphe de Rothschild

Lead sponsor

Source ClinicalTrials.gov